Clazact 4.5 Injection
Marketer
Louis and Clark Pharmaceutical
Salt Composition
Piperacillin (4000mg) + Tazobactum (500mg)
Overview Clazact 4.5 Injection
Clazact 4.5 Injection combines two antibiotics to combat diverse bacterial infections by eliminating microorganisms. Administration is exclusively by a medical professional; self-injection is prohibited. Dosage and frequency are determined by your physician based on your condition's severity, adhering strictly to their prescription. Common side effects may include nausea, vomiting, diarrhea, and skin rashes. Injection site reactions such as pain, swelling, or redness are also possible. Persistent or worsening side effects necessitate immediate medical consultation. Prior to use, inform your doctor of any antibiotic allergies, kidney, or liver issues; adjustments to dosage or alternative medication may be necessary. Generally, this injection is considered safe for pregnant and breastfeeding individuals under medical guidance.
Primary Ingredients of Clazact 4.5 Injection
The provided text is "undefined," offering no content to rephrase. Therefore, no rewritten text can be provided.
Uses of Clazact 4.5 Injection
Infections caused by bacteria
Major Benefits of Clazact 4.5 Injection:
The medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Clazact 4.5 Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Clazact 4.5 Injection:
This medication will be administered by your physician or their registered nurse; self-medication is strictly prohibited.
How Clazact 4.5 Injection works:
Clazact 4.5 Injection unites Piperacillin, an antibiotic, with Tazobactum, a beta-lactamase inhibitor. Piperacillin combats bacterial growth by disrupting the synthesis of their protective cell walls. The addition of Tazobactum overcomes bacterial resistance mechanisms, thereby improving Piperacillin's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Clazact 4.5 Injection can be taken with alcohol without adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Clazact 4.5 is typically deemed safe for use during gestation. Preclinical trials in animals have revealed minimal or no negative impacts on fetal development; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Administration of Clazact 4.5 Injection is considered safe for breastfeeding mothers. Research in humans indicates negligible transfer of the medication into breast milk, posing no known risk to the infant.
DrivingCONSULT YOUR DOCTOR
Clazact 4.5 Injection's effect on driving ability is undetermined. Refrain from operating a vehicle if experiencing symptoms impairing concentration or reaction time.
KidneyCAUTION
Exercise caution when administering Clazact 4.5 Injection to individuals with impaired renal function; dosage modification may be necessary. Seek medical advice.
LiverSAFE IF PRESCRIBED
The use of Clazact 4.5 Injection in individuals with hepatic impairment appears to pose minimal risk. Current evidence indicates dose modification may be unnecessary; however, medical advice is recommended.
What if you forget to take Clazact 4.5 Injection :
Omit a Clazact 4.5 Injection dose? Seek your physician's advice.
Facts to Know About Clazact 4.5 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |



